Tandem Diabetes Care (TNDM) Operating Expenses (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Operating Expenses came in at $154.2 million in Q1 2026, down 35.55% YoY from $239.3 million in Q1 2025, and down 3.11% on a QoQ basis from $159.2 million in Q4 2025.
Tandem Diabetes Care (TNDM) Operating Expenses (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Operating Expenses data on file, last reported at $154.2 million in Q1 2026.
- Quarterly Operating Expenses fell 35.55% year-over-year to $154.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $648.2 million (down 6.28% YoY) and the FY2025 annual result came in at $733.3 million, up 24.56% from the prior year.
- Operating Expenses declined to $154.2 million in Q1 2026, from $159.2 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $239.3 million in Q1 2025 to a low of $106.4 million in Q1 2022.
- A 5-year average of $151.9 million and a median of $150.7 million in 2024 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2023 — Operating Expenses soared 97.99% — and 2026, when it sank 35.55%.
- Tracing TNDM's Operating Expenses over 5 years: stood at $133.3 million in 2022, then slipped by 3.71% to $128.4 million in 2023, then grew by 23.12% to $158.0 million in 2024, then gained by 0.72% to $159.2 million in 2025, then decreased by 3.11% to $154.2 million in 2026.
- The last three Operating Expenses figures came in at $154.2 million (Q1 2026), $159.2 million (Q4 2025), and $157.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 10.90 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 2.84 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 3.59 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 2.67 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 846.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 511.70 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 1.44 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -741.59 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 398.30 Mn |
| 10 | Tandem Diabetes Care | 1.58 Bn | 1.13 Bn | 144.78 Mn | 158.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 158.57 Mn |
| Mar 31, 2026 | 154.22 Mn |
| Dec 31, 2025 | 159.17 Mn |
| Sep 30, 2025 | 157.16 Mn |
| Jun 30, 2025 | 177.67 Mn |
| Mar 31, 2025 | 239.29 Mn |
| Dec 31, 2024 | 158.04 Mn |
| Sep 30, 2024 | 150.75 Mn |
| Jun 30, 2024 | 143.57 Mn |
| Mar 31, 2024 | 136.35 Mn |
| Dec 31, 2023 | 128.36 Mn |
| Sep 30, 2023 | 121.30 Mn |
| Jun 30, 2023 | 140.54 Mn |
| Mar 31, 2023 | 210.72 Mn |
| Dec 31, 2022 | 133.30 Mn |
| Sep 30, 2022 | 151.92 Mn |
| Jun 30, 2022 | 114.19 Mn |
| Mar 31, 2022 | 106.43 Mn |
| Dec 31, 2021 | 100.99 Mn |
| Sep 30, 2021 | 89.03 Mn |